Lilly Backs Microsoft In Patent Battle Before Supreme Court
Executive Summary
Lilly and Microsoft are usually at odds when debating how to revise the patent system, but Lilly stood in the software giant's corner as its patent battle with AT&T went before the U.S. Supreme Court
You may also be interested in...
ANDA Challenges To Formulation Patents May Get Easier After KSR Ruling
The pharmaceutical industry could have a tougher time protecting certain drug patents - particularly those in ANDA litigation - following a U.S. Supreme Court decision that expands the situations under which an invention can be considered obvious
ANDA Challenges To Formulation Patents May Get Easier After KSR Ruling
The pharmaceutical industry could have a tougher time protecting certain drug patents - particularly those in ANDA litigation - following a U.S. Supreme Court decision that expands the situations under which an invention can be considered obvious
Patent Reform Bill Gets Cool Reception From Rx Industry; Damage Cap Is Worry
A new patent reform bill introduced in Congress is likely to undergo revisions in the face of criticism from the pharmaceutical industry